Form 4: DENTSPLY SIRONA Director Buys Shares

DENTSPLY SIRONA Inc. reports a significant stock purchase by Director Brian T. Gladden, acquiring over 9,900 shares.

Summary

• Director Brian T. Gladden acquired 9,985.022 shares of DENTSPLY SIRONA Inc. common stock on June 15, 2026.
• The purchase was made at a weighted average price of $10.015 per share, with individual transaction prices ranging from $10.015 to $10.0156.
• Following this transaction, Mr. Gladden beneficially owns 61,848.544 shares of common stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive filing due to the significant share purchase by a company director, indicating insider confidence.

Positives

• Director Brian T. Gladden demonstrated confidence in the company by purchasing a substantial number of shares.
• The purchase indicates a belief in the future value and performance of DENTSPLY SIRONA Inc.

Future Outlook

No specific forward-looking statements or guidance are present in this filing, which is a statement of changes in beneficial ownership.

Industry Context

StockSavvy.ai notes that insider purchases, particularly by directors, are often viewed as positive signals by the market, suggesting a belief in the company's intrinsic value and future prospects within the dental technology and healthcare sector.

Stakeholder Impact

• Shareholders may view this purchase positively, interpreting it as a sign of confidence from a key insider.
• Employees may also see this as a positive indicator of the company's stability and future prospects.

Key Dates

Recommendation

The purchase by a director is a positive signal, but as a Form 4 filing, it represents a single transaction and does not provide comprehensive financial or strategic information to warrant a strong buy or sell recommendation. It suggests confidence but requires further analysis of the company's overall performance and outlook.

Keywords

DENTSPLY SIRONA, XRAY, Director Purchase, Insider Trading, Form 4, Common Stock, Securities Ownership